Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

AVELLA SPECIALTY PHARMACY — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report (No Activity)

AVELLA SPECIALTY PHARMACY

via DA VINCI GROUP

4th Quarter (Oct 1 - Dec 31) · 2013Posted Jan 20, 2014Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: AVELLA SPECIALTY PHARMACY
Description: Pharmaceuticals/Pharmacy Service
Location: Arizona · United States of America

Registrant

Firm: DA VINCI GROUP
Description: Government Affairs Firm
Location: Purcellville, Virginia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.